Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving oxidoreductase
Patent
1999-05-03
2000-02-08
Prats, Francisco
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving oxidoreductase
435 25, C12Q 128, C12Q 126
Patent
active
060226994
ABSTRACT:
An improved model of endotoxin-induced inflammation is obtained by eliminating the interference in the biochemical assay of myeloperoxidase caused by endogenous reductants and cellular constituents containing free thiol functional groups. The interference was eliminated by 1) extensively diluting soluble, interfering substances and 2) blocking tissue sulfhydril functional groups during tissue homogenization. The improved model can be used to assess the therapeutic potential of anti-inflammatory agents. For example, the model can be used to evaluate topically administrable ophthalmic anti-inflammatory agents in Lewis rats.
REFERENCES:
Graff et al., J. Pharmacol. Toxicol. Methods 39 (3) 169-178, 1998.
Haugaard et al., Anal. Biochem 116(2): 341-343, 1981.
Nelson et al., Anal Biochem 49: 471-478, 1972.
Baatz et al., Invest Ophthalmol Vis Sci 36: 1960-1967 (1995).
Bhattacherjee et al., Invest Ophthalmol Vis Sci 24: 196-202 (1983).
Bradley et al., J Invest Dermatol 78: 206-209 (1982).
Claiborne et al., Biochemistry 18: 2324-2329 (1979).
Costagliola et al., Exp Eye Res 43: 905-914 (1986).
Cousins et al., Exp Eye Res 39: 665-676 (1984).
Cramer et al., Adv Exp Med Biol 121(A):91-9 (1979).
De Berardinis et al., Exp Eye Res 4: 179-186 (1965).
Egan et al., Agents Actions 29: 266-276 (1980).
Floris et al., Eur J Biochem 207: 697-702 (1992).
Forrester et al., Graefes Arch Klin Exp Ophthalmol 213: 221-233 (1980).
Graff et al., Prostaglandins 38: 473-496 (1989).
Grisham et al., Methods in Enzymology, vol. 186, Ed. Packer et al., San Diego: Academic Press, pp. 729-742 (1990).
Hockwin et al., Glutathione: Metabolism and physiological functions, Ed., Vina, Boca Raton: CRC Press, pp. 207-215 (1990).
Krawisz et al., Gastroenterology 87: 1344-1350 (1984).
Liem et al., Anal Biochem 98: 388-393 (1979).
Marquez et al., J Biol Chem 265: 5666-5670 (1990).
Nelson et al., Anal Biochem 49: 474-478 (1972).
Saxena et al., Exp Eye Res 55: 461-468 (1992).
Schultz et al., Arch Biochem Biophys 96: 465-467 (1962).
Tsuji et al., Exp Eye Res 64: 31-36 (1997).
Udelsman et al., Curr Probl Surg 31: 655-720 (1994).
Varma et al., Ophthalmic Res 20: 164-173 (1988).
Vinegar et al., J Pharmacol Exp Ther 166: 96-103 (1969).
Whitcup et al., Invest Ophthalmol Vis Sci 33:2626-2630 (1992).
Williams et al., Curr Eye Res 2: 465-470 (1982).
Williams et al., Exp Eye Res 39: 261-265 (1984).
Williams et al., Exp Eye Res 42: 211-218 (1986).
Winter et al., Proc Soc Exp Biol Med 111: 544-547 (1962).
Wise et al., Carcinogenesis 5: 1499-1503 (1984).
Wise et al., Carcinogenesis 6: 579-583 (1985).
Worthington Biochemical Corporation (1972) Peroxidase. Worthington Enzyme Manual.
Graff Gustav
Hellberg Mark R.
Alcon Laboratories Inc.
Coe Susan D.
Prats Francisco
Ryan Patrick M.
LandOfFree
Myeloperoxidase assay of endotoxin-induced inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Myeloperoxidase assay of endotoxin-induced inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myeloperoxidase assay of endotoxin-induced inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1679975